CD4 and Alzheimer disease: While we observed no significant difference in the frequency of Flu-specific CD4+ T cells between these two patient populations (p = 0.39), we determined that frequencies of pooled TAA-specific CD4+ T cells in patients with AD were significantly increased when compared with patients who had been rendered NED as a consequence of prior therapy (p < 0.008; Figure 2A).